[{"NetIncomeLoss_1_Q2_USD":-22045000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":44.4,"DepreciationAndAmortization_2_Q2_USD":1705000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":15703000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":8326000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":15744000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":48.77,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":55000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":29478000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":608000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":54137000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":8013000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-350000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":1479000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":41000.0,"AssetsCurrent_0_Q2_USD":428219000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4307000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4268000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1152000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":179917000.0,"UnrecognizedTaxBenefits_0_Q2_USD":686000.0,"CommonStockSharesIssued_0_Q2_shares":20185000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":323314000.0,"Assets_0_Q2_USD":467767000.0,"ShareBasedCompensation_2_Q2_USD":10163000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":6972000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":805000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-789000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-84000.0,"Liabilities_0_Q2_USD":31735000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":41506000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":48.77,"EarningsPerShareBasic_2_Q2_USD":-1.51,"EarningsPerShareBasic_1_Q2_USD":-1.09,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":20131000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":20171000.0,"AssetsFairValueDisclosure_0_Q2_USD":399451000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1703000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1222000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":545000.0,"AccountsReceivableNetCurrent_0_Q2_USD":20132000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-10404000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-7110000.0,"CommonStockValue_0_Q2_USD":202000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":24493000.0,"LiabilityForUncertainTaxPositionsNoncurrent_0_Q2_USD":686000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1451000.0,"CostsAndExpenses_2_Q2_USD":93874000.0,"CostsAndExpenses_1_Q2_USD":49832000.0,"AssetRetirementObligationsNoncurrent_0_Q2_USD":308000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-31162000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-22395000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":15000.0,"OtherAssetsNoncurrent_0_Q2_USD":92000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":77126000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2644000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":338576000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":66.81,"ResearchAndDevelopmentExpense_2_Q2_USD":78171000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":345000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":5444000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-789000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-350000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":481000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-40777000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-29155000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":534000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5280000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-19469000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":20171000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":20131000.0,"LiabilitiesCurrent_0_Q2_USD":26618000.0,"AccountsPayableCurrent_0_Q2_USD":5699000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":3886000.0,"NonoperatingIncomeExpense_2_Q2_USD":1222000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":32140000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1985000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1033000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":29478000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":77734000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":76000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":17000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":25801000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":7038000.0,"NetIncomeLoss_2_Q2_USD":-30373000.0,"NonoperatingIncomeExpense_1_Q2_USD":545000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":171586000.0,"EarningsPerShareDiluted_1_Q2_USD":-1.09,"EarningsPerShareDiluted_2_Q2_USD":-1.51,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":51875000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":20132000.0,"OperatingIncomeLoss_2_Q2_USD":-41999000.0,"OperatingIncomeLoss_1_Q2_USD":-29700000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":298821000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":44.76,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":26.27,"LiabilitiesAndStockholdersEquity_0_Q2_USD":467767000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2592000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":10163000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5280000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":105000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5175000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":2517000.0,"ProfitLoss_2_Q2_USD":-30373000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":994000.0,"StockholdersEquity_0_Q2_USD":436032000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":318000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":322874000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-956000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3886000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2312000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":97199000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-10005000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-3360000.0,"CommonStockSharesOutstanding_0_Q2_shares":20185000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"AccruedProfessionalFeesCurrent_0_Q2_USD":684000.0,"Ticker":"ENTA","CIK":"1177648","name":"ENANTA PHARMACEUTICALS INC","OfficialName":"Enanta Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1492537180.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]